Clinical Research Directory
Browse clinical research sites, groups, and studies.
Beta-amyloid PET/CT to Measure Potential Therapeutic Response in AL-CA
Sponsor: Peking Union Medical College Hospital
Summary
This was a single center, prospective cohort study that is evaluating the ability of beta-amyloid dynamic PET/CT to detect potential therapeutic changes in subjects under treatment for AL-CA after one year had elapsed since their baseline beta-amyloid PET/CT. Demographic, clinical and PET imaging data were collected to characterize potential changes since their baseline scans.
Official title: A Follow-Up Study to Monitor Therapeutic Response in Light Chain Cardiac Amyloidosis Using Beta-amyloid PET/CT
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2020-06-03
Completion Date
2027-12-31
Last Updated
2026-09-21
Healthy Volunteers
No
Conditions
Interventions
11C-PIB
A dosage range between 5.0-20.0 mCi of 11C-PIB will be injected by a PET-certified medical professional followed by 5ml 0.9% sodium chloride (normal saline) flush.
18F-Florbetapir
A dosage range between 6.0-12.0 mCi of 18F-Florbetapir will be injected by a PET-certified medical professional followed by 5ml 0.9% sodium chloride (normal saline) flush.
Locations (1)
Peking Union Medical College Hospital
Beijing, China